Fort Lee, NJ, Aug. 17, 2023 Nuvectis Pharma, Inc. , a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious.
FDA Grants Orphan Drug Designation to NXP800 for Cholangiocarcinoma onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) CEO Ron Bentsur acquired 750 shares of the stock in a transaction dated Monday, June 26th. The stock was acquired at an average cost of $16.50 per share, with a total value of $12,375.00. Following the purchase, the chief executive officer now owns 3,230,779 shares of the company’s […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Rating) CEO Ron Bentsur purchased 750 shares of the firm’s stock in a transaction that occurred on Monday, June 26th. The stock was bought at an average cost of $16.50 per share, for a total transaction of $12,375.00. Following the completion of the purchase, the chief executive officer now […]